Dr. Amy C. Bumgardner, MD

Dr. Bumgardner practices at Complete Dermatology in Sugarland, Texas.

Dr. Bumgardner's NPI, 1184757106, was assigned on March 13, 2007. Dr. Bumgardner graduated from McGovern Medical School in 2003. Dr. Bumgardner's Texas license number on file is M3939.

Dr. Bumgardner's primary practice is Complete Dermatology, at 7616 Branford Pl, Sugarland, TX 77479 in Fort Bend County. The practice phone is (281) 857-6870.

Dr. Bumgardner's primary practice is Complete Dermatology in Sugarland, Texas. The medical group on file is Complete Dermatology. Dmand AI also links Dr. Bumgardner to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bumgardner practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bumgardner's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bumgardner is board certified in dermatology by the American Board of Dermatology. Dr. Bumgardner has a license on file in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Bumgardner treats.

CMS data shows 5,783 Medicare services from Dr. Bumgardner across 21 procedure codes in 2024, for 1,152 Medicare patients. Medicare paid $223,249 for them. Every service was in an office.

CMS counts 1,152 Medicare patients who saw Dr. Bumgardner in 2024. The largest group is 65 to 74, with 596 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bumgardner's median patient age at 68, with 61% women.

In 2024, Dr. Bumgardner wrote 1,451 Medicare Part D claims for 511 patients. 86% of them were for generic drugs. CMS names the drug for 1,248 of them, across 31 drugs with 11 or more claims each, at $558,918 in total drug cost. In 2023, CMS named 1,274 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bumgardner for performance year 2024, reported individually. Dr. Bumgardner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,968 procedures of removal of skin lesions by Dr. Bumgardner, more than 98% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bumgardner in 2024. The most frequent topics are Erythema. Dr. Bumgardner's most frequent co-authors are Janna Kate Nunez-Gussman, MD, Jaime Antonio Tschen, MD and Kristin Rose Wolf, MD.

CMS Open Payments shows 1,749 general payments to Dr. Bumgardner from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $5,451.

Dmand AI lists 1 award for Dr. Bumgardner.

Dr. Bumgardner graduated from McGovern Medical School in 2003. Dr. Bumgardner is a member of AAD.

Dr. Bumgardner is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.